Aimovig and Pregnancy, Breastfeeding, and More

Medical note: This article is for educational publishing only and is not a substitute for care from an OB-GYN, neurologist, pharmacist, or other licensed healthcare professional. Anyone who is pregnant, planning pregnancy, breastfeeding, or managing migraine after delivery should talk with their healthcare provider before starting, stopping, or changing Aimovig.

What Is Aimovig?

Aimovig is the brand name for erenumab-aooe, a prescription injection used to help prevent migraine in adults. It belongs to a newer group of migraine preventive treatments called CGRP monoclonal antibodies. CGRP stands for calcitonin gene-related peptide, a molecule involved in migraine pathways. Aimovig works by blocking the CGRP receptor, which is like putting a “do not enter” sign on one of the migraine system’s busiest doorways.

Unlike pain relievers taken during a migraine attack, Aimovig is used on a schedule, usually once per month, to reduce how often migraine attacks happen. It is not designed to treat a migraine that has already started. For many adults with frequent migraine, that distinction matters: prevention is the umbrella; acute medicine is the raincoat.

Can You Use Aimovig During Pregnancy?

The honest answer is: there is not enough human pregnancy data to say Aimovig is completely safe during pregnancy. Current U.S. prescribing information states that it is not known whether Aimovig can harm an unborn baby. Because pregnancy is a time when medication decisions become especially delicate, most experts recommend a cautious, individualized approach.

This does not mean every accidental exposure is automatically expected to cause harm. Available reports have not shown a clear pattern of birth defects or pregnancy loss linked to Aimovig, but the number of reported cases is still limited. In medicine, “limited data” is not the same as “danger proven,” but it is also not the same as “green light, no worries.” It is more like a yellow traffic light with a very serious OB-GYN standing nearby.

Why the Caution?

Aimovig is a monoclonal antibody, which is a large protein-based medicine. Monoclonal antibodies can behave differently during pregnancy depending on timing, dose, and the specific antibody involved. Placental transfer is generally lower early in pregnancy and increases later, especially in the second and third trimesters. Since CGRP also plays roles in blood vessel function, clinicians are careful when considering CGRP-blocking therapies during pregnancy.

Professional migraine resources commonly recommend avoiding CGRP monoclonal antibodies during pregnancy when possible. Some guidance suggests stopping these medications several months before trying to conceive because they stay in the body for a long time. If you are planning pregnancy, this is a conversation to have before the calendar starts filling up with ovulation apps, prenatal vitamins, and enthusiastic relatives asking suspiciously personal questions.

What If You Become Pregnant While Taking Aimovig?

If you discover you are pregnant while using Aimovig, do not panic, and do not make medication changes in a vacuum. Contact your prescribing clinician and pregnancy care provider. They can review when your last dose was taken, how severe your migraine history is, what other medications you use, and whether continuing, pausing, or switching treatment makes sense.

There is also a pregnancy exposure registry for Aimovig. A registry collects health information from people exposed to a medication during pregnancy and tracks pregnancy and infant outcomes. These registries are important because they help build the real-world safety knowledge that future patients and clinicians rely on.

Aimovig and Breastfeeding

Breastfeeding raises a similar question: not enough is known. Current prescribing information says it is not known whether Aimovig passes into human breast milk, affects a breastfed infant, or affects milk production. That does not automatically mean it is unsafe, but it does mean the decision should be made with a healthcare provider.

Lactation references note that erenumab is a very large protein molecule, so the amount that enters milk may be low, and any swallowed amount may be partly broken down in the baby’s digestive tract. However, newborns and preterm infants are more vulnerable, so extra caution is often recommended during the earliest weeks after birth.

Questions to Ask Your Doctor While Breastfeeding

• How severe are my migraine attacks without preventive medication?
• Is my baby newborn, preterm, medically fragile, or older and healthy?
• Are there better-studied migraine options during lactation?
• Would waiting a short period postpartum before restarting Aimovig reduce exposure?
• What symptoms should I watch for in myself or my baby?

Planning Pregnancy While Managing Migraine

For people with migraine, pregnancy planning should include more than prenatal vitamins and Pinterest nursery boards. Migraine can improve during pregnancy for some people, especially later in pregnancy, but others continue to have disabling attacks. Migraine with aura, chronic migraine, sleep disruption, dehydration, stress, and medication changes can all complicate the picture.

If you use Aimovig and want to become pregnant, ask your neurologist and OB-GYN about a preconception migraine plan. This plan may include stopping Aimovig before trying to conceive, switching to a better-studied preventive option, using non-drug strategies more aggressively, and choosing pregnancy-compatible acute treatments for breakthrough attacks.

Non-Drug Migraine Strategies During Pregnancy

Non-medication tools are not magical, but they can be surprisingly powerful when used consistently. Helpful strategies may include regular sleep, steady hydration, balanced meals, gentle exercise if approved by your clinician, relaxation training, trigger tracking, and avoiding skipped meals. Migraine loves chaos. A predictable routine does not eliminate migraine for everyone, but it can make the brain less likely to slam the emergency button.

Some patients also discuss neuromodulation devices, nerve blocks, physical therapy, magnesium, riboflavin, or other options with their clinicians. The key phrase is “with their clinicians,” because even supplements can matter during pregnancy and breastfeeding.

Possible Side Effects of Aimovig

Common side effects of Aimovig include injection site reactions such as pain, redness, or swelling, as well as constipation. Some people also report cramps or muscle spasms. Serious side effects can include allergic reactions, severe constipation with complications, high blood pressure, and Raynaud’s phenomenon, a circulation problem that can affect the fingers and toes.

These side effects are important for anyone using Aimovig, but they become especially relevant around pregnancy and postpartum. Pregnancy itself can affect blood pressure, digestion, circulation, and fluid balance. Postpartum life can add sleep deprivation, dehydration, stress, and irregular mealsthe classic “migraine buffet,” unfortunately with no dessert.

When to Call a Healthcare Provider

Call a healthcare provider promptly if you experience severe constipation, constant abdominal pain, vomiting, swelling or bloating, symptoms of an allergic reaction, increased blood pressure, or new finger or toe color changes, numbness, coolness, or pain. If symptoms feel urgent or involve trouble breathing or swelling of the face, mouth, tongue, or throat, seek emergency care.

Aimovig, Fertility, and Family Planning

There is no strong evidence that Aimovig directly affects fertility, but pregnancy planning still matters because the medication remains in the body for a while after the last dose. If you are actively trying to conceive, your provider may recommend a washout period. The exact plan depends on your migraine severity, past treatment response, other health conditions, and how much risk uncertainty you are comfortable accepting.

A practical approach is to schedule a preconception visit with both your migraine specialist and pregnancy care provider. Bring a list of current medications, supplements, migraine triggers, attack frequency, and what has or has not worked in the past. Your future self will thank you for not trying to reconstruct your medication history from random pharmacy receipts and half-remembered app notifications.

Alternatives to Discuss During Pregnancy and Breastfeeding

Medication choices during pregnancy and breastfeeding must be personalized. Some options have more pregnancy or lactation experience than CGRP monoclonal antibodies, but none should be started casually. Depending on the patient, clinicians may discuss lifestyle treatment, behavioral therapy, nerve blocks, certain vitamins or supplements, selected preventive medications, or specific acute treatments.

For acute migraine attacks, some medications are considered more familiar in pregnancy than others, but timing matters. For example, NSAID use is often limited during pregnancy and may be avoided at certain stages. Triptans, acetaminophen, anti-nausea medications, and other therapies may be considered in selected cases. The safest choice depends on trimester, medical history, migraine pattern, and other medications.

Practical Checklist Before Using Aimovig

• Tell your provider if you are pregnant, planning pregnancy, breastfeeding, or planning to breastfeed.
• Review your blood pressure history and any circulation problems.
• Discuss constipation risk, especially if you already use medications that slow bowel movements.
• Ask whether you should enroll in a pregnancy exposure registry if exposed during pregnancy.
• Create a written migraine plan for pregnancy, delivery, and postpartum.
• Keep a migraine diary to track frequency, severity, triggers, and medication use.

Real-Life Experience: What Patients Often Think About

Many people who use Aimovig describe the decision around pregnancy or breastfeeding as emotionally complicated. On one side is the desire to reduce any uncertain exposure during pregnancy or lactation. On the other side is the reality of migraine, which can be far more than “just a headache.” Severe migraine can mean vomiting, light sensitivity, missed work, missed family time, dehydration, emergency visits, and days spent in a dark room negotiating with your nervous system like it is a tiny, angry landlord.

A common experience is fear after an unplanned pregnancy exposure. Someone may take their monthly injection, then find out two weeks later that they are pregnant. The first reaction is often panic. The more helpful next step is to call the prescribing clinician and OB-GYN, document the exposure date, and review current evidence. Accidental exposure does not mean something bad will happen, but it does deserve professional follow-up.

Another common experience happens during breastfeeding. A parent may have been migraine-free during pregnancy, then suddenly postpartum migraine returns with full dramatic lighting. The baby is waking every two hours, meals are irregular, hydration is a distant memory, and the migraine brain says, “Excellent, let’s make this harder.” In that situation, the question becomes whether the benefits of restarting Aimovig outweigh the uncertainty for the breastfed infant.

Some breastfeeding parents may decide with their clinician to wait until the baby is older before restarting Aimovig. Others may consider different treatments with more lactation experience. A few may restart because their migraine disability is severe and other options have failed. None of these choices should be framed as lazy, reckless, or overly cautious. They are medical decisions made in real life, where perfect data rarely arrives on schedule.

Patients also often learn that migraine care works best when it is planned before a crisis. A written postpartum migraine plan can include who to call, what acute medication is allowed, whether breastfeeding timing matters for a chosen treatment, how to manage nausea, when to seek urgent care, and how family members can help. “Please bring me water, take the baby for twenty minutes, and turn off that heroic overhead light” is not a luxury request. It is migraine management.

Another useful experience-based tip is to track migraine patterns across hormone changes. Some people improve in pregnancy and flare after delivery. Others worsen in the first trimester and stabilize later. Some notice migraine attacks around sleep loss, missed meals, weather shifts, or breastfeeding-related dehydration. A simple diary can help a clinician decide whether preventive therapy is needed or whether targeted lifestyle and acute-treatment adjustments may be enough.

Finally, many people feel guilty about needing migraine medicine during pregnancy or breastfeeding. That guilt is common, but it is not medically useful. The goal is not to win a toughness contest. The goal is to protect both parent and baby by making informed, balanced decisions. Untreated severe migraine can also carry consequences, including poor sleep, poor nutrition, dehydration, stress, and reduced ability to function. A thoughtful treatment plan is not selfish. It is healthcare.

Conclusion

Aimovig can be an effective preventive option for adults with migraine, but pregnancy and breastfeeding require extra caution. The main issue is not that Aimovig has been proven harmful in pregnancy or lactation; it is that human data remain limited. Current labeling says it is unknown whether Aimovig can harm an unborn baby or pass into breast milk. Expert migraine resources commonly recommend avoiding CGRP monoclonal antibodies during pregnancy when possible and making breastfeeding decisions case by case.

The best next step is a personalized plan. If you are pregnant, planning pregnancy, breastfeeding, or thinking ahead, speak with your neurologist, OB-GYN, and pharmacist. Migraine is complicated enough without guessing your way through medication decisions. With the right team, you can weigh the benefits, risks, uncertainties, and alternatives in a way that fits your health and your baby’s needs.